Phase entropy of gated SPECT-MPI for predicting major adverse cardiovascular events: incremental prognostic value beyond perfusion and function
Frontiers in Cardiovascular Medicine · 07.07.2026 · 13
DOI: 10.3389/fcvm.2026.1839622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 07.07.2026. Verfasst von Yuxin Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Gated SPECT myocardial perfusion imaging (MPI) phase analysis provides a quantitative assessment of left ventricular mechanical synchrony, enabling cardiovascular risk stratification. Phase entropy, a derived imaging biomarker, reflects the spatiotemporal heterogeneity of myocardial contraction. However, its prognostic significance and clinically applicable threshold values have not been rigorously validated. This study aimed to determine the independent prognostic value of phase entropy for predicting major adverse cardiovascular events (MACE).
Results
Among 1,674 coronary artery disease patients (median age 62.0 years, 66.2% male) followed for a median 36.6 months, an U-shaped association between phase entropy and major adverse cardiovascular events was identified ( P = 0.005). Patients with abnormal phase entropy (>53% or ≤31%) exhibited significantly lower survival than those with normal values (31%–53%, P < 0.001). After multivariable adjustment, phase entropy remained an independent major adverse cardiovascular events predictor, and its addition to a model including total perfusion deficit (TPD) and left ventricular ejection fraction (LVEF) improved major adverse cardiovascular events prediction ( P < 0.05).
Conclusion
Phase entropy ≤31% or >53% correlates with reduced survival. This biomarker independently predicts major adverse cardiovascular events and provides incremental prognostic value beyond TPD and LVEF, with ≤31% identifying a high-risk subgroup that merits intensified clinical monitoring.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China.
- Shanxi Key Laboratory of Molecular Imaging, Shanxi Medical University, Taiyuan, Shanxi, China.
- Collaborative Innovation Center for Molecular Imaging of Precision Medicine Shanxi Medical University, Taiyuan, Shanxi, China.
- Laboratory for Molecular Imaging, Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- Department of Nuclear Medicine, the Third Affiliated Hospital of Soochow University, Changzhou, China.
- Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University, Changzhou, China.
Zitieren
APA
Xiao, Y., Zhao, Y., Wu, Z., Zhang, X., Wang, Y., Yang, M., & Li, S. (2026). Phase entropy of gated SPECT-MPI for predicting major adverse cardiovascular events: incremental prognostic value beyond perfusion and function. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1839622
Vancouver
Xiao Y, Zhao Y, Wu Z, Zhang X, Wang Y, Yang M, et al. Phase entropy of gated SPECT-MPI for predicting major adverse cardiovascular events: incremental prognostic value beyond perfusion and function. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1839622
BibTeX
@article{Xiao2026,
author = {Xiao, Yuxin and Zhao, Yuting and Wu, Zhifang and Zhang, Xiaoli and Wang, Yuetao and Yang, Minfu and Li, Sijin},
title = {Phase entropy of gated SPECT-MPI for predicting major adverse cardiovascular events: incremental prognostic value beyond perfusion and function},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1839622}
}
EUVIMED